Radhakrishnan Srikanth
Known title: Chief Science &Techn. OfficerCIK: 0002098678
Associated companies
Transaction History
| LUNG | ▼ Sell | Open Market | 2,643 | $6K | 9/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 2,121 | $5K | 9/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 3,618 | $8K | 9/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 5,863 | $13K | 9/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 5,969 | $9K | 6/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 2,153 | $3K | 6/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 3,684 | $6K | 6/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 2,691 | $4K | 6/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 3,068 | $4K | 3/2/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 2,461 | $4K | 3/2/2026 | View on chart |
| LUNG | ▲ Buy | Grant | 175,000 | $0 | 3/2/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 4,198 | $6K | 3/2/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 756 | $1K | 3/2/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27
Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.